Abbott Laboratories, of Abbott Park, Ill., said that its next-generation Freestyle Libre 2 integrated continuous glucose monitoring system is now available to Medicare patients.
Healthfirst, a New York-based not-for-profit health insurance company, said that it will offer coverage for Apostherapy – an at-home option for knee and low back pain to help patients living with such conditions from New York-based Apostherapy.
Biocartis Group NV, of Mechelen, Belgium, reported the expansion of its collaboration with London-based Lifearc, an independent medical research charity, with a new agreement aimed at the development of prototype assays in the field of infectious and immune related diseases on Biocartis’ fully automated molecular diagnostics platform Idylla.
Cardiologs, which has a presence in Boston and Paris, reported an exclusive distribution agreement in France with Paris-based Microport CRM, which focuses on cardiac rhythm management (CRM), for the reselling of its cloud analysis solution for Holter ECGs.
Combinati, of Palo Alto, Calif., reported a whole product solution for the quantification of SARS-CoV-2 viral targets. Combinati's COVID-19 solution consists of the Absolute Q system, microfluidic array partitioning plates, required reagents and the |Q| SARS-CoV-2 Triplex Assay. The system features an identical workflow to quick polymerase chain reaction (PCR) with the added accuracy and sensitivity benefits of digital PCR (dPCR) in a single benchtop instrument. The Absolute Q dPCR platform has one hands-on step and provides results in 90 minutes.
Redlands, Calif.-based Esri released a new app to help stakeholders and the public understand how COVID-19 is trending in every state and county in the U.S. The daily updated app, which visualizes trend lines for new cases, deaths, as well as cumulative cases, tracks case data compiled by Johns Hopkins University from January to the present. Users can see where cases are spiking, declining or holding steady.
Healthplanone Inc., of Trumbull, Conn., and Fort Worth, Texas-based Fds Inc. have formed a strategic partnership to provide support for pharmacies using the Fds platform and their patients seeking assistance in evaluating and enrolling in Medicare plans.
Golden Valley, Minn.-based Inspire Medical Systems Inc. said that Humana Inc., of Louisville, Ky., will provide coverage for the company’s Inspire therapy, effective Aug. 27.
Ion Beam Applications SA (IBA), of Louvain-La-Neuve, Belgium, reported a contract with Sichuan Cancer Hospital & Institute to install a Proteus Plus proton therapy system in Chengdu, China. The contract is worth more than €50 million (US$57 million) to IBA. The initial down payment is expected within 90 days.
Burlington, Mass.-based Laborie Medical Technologies, in partnership with Signet Healthcare Partners, a growth equity firm specializing in healthcare investments, signed an agreement to acquire Mechanicsburg, Pa.-based GI Supply, which focuses on specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons and interventional radiologists. The acquisition is expected to close once approved by regulatory authorities. GI Supply and Laborie will continue to operate independently, with the former still being led by its CEO Kristi Dahlke and its existing leadership team. No financial details were disclosed.
Medgyn Products Inc., of Addison, Ill., said that through one of its subsidiaries, it has completed the acquisition of Indianapolis-based Thomas Medical from Biomerics Atl LLC, based in Salt Lake City. Thomas Medical will operate as an independent division of Medgyn, and all products will continue to be manufactured in the U.S. without any disruption. Thomas Medical will be retaining its brand. The acquisition is effective immediately. No financial details were disclosed.
Alexandria, Va.-based Mellingmedical LLC has signed a distribution agreement with Leica Microsystems GmbH, of Wetzlar, Germany, for the latter’s neurological, spine, ophthalmic, otolayngologic, dental and plastic reconstructive microscope portfolio. Mellingmedical supplies medical devices and pharmaceuticals to federal health facilities under the Department of Veteran Affairs’ Veterans First procurement program.
Mevion Medical Systems Inc., of Littleton, Mass., and Proton International LLC, of Palo Alto, Calif., have signed a two-system contract to bring Mevion’s S250i proton therapy system with Hyperscan Pencil Beam scanning to new centers in South Texas and the Southeast U.S.
Newomics Inc., of Berkeley, Calif., said it has completed the final link in creating a worldwide distribution and support network. The network includes MS Wil BV (Europe), Amr Inc. (Japan), Wise Analysis Instruments (Taiwan) and Neoline Technology Co. (China), in addition to its own U.S.-based salesforce and co-marketing agreements with mass spectrometry vendors.
The Austin-based Texas Cardiac Arrhythmia Institute at St. David’s Medical Center reported that its physicians are among the first to participate in a clinical trial to evaluate the Ice Catheter, an intra-cardiac echocardiography catheter made by Nuvision Inc., of Huntington Beach, Calif.
Össur hf, a producer of prosthetic and noninvasive orthopedic technologies headquartered in Reykjavík, Iceland, has established Össur Japan. The Tokyo-based entity will be led by Shoko Nireki.
The Chicago-based Pulmonary Fibrosis Foundation issued a position statement outlining diagnostic protocol for conducting high-resolution computed tomography (HRCT) of the thorax for interstitial lung disease. The statement highlights important patterns in idiopathic pulmonary fibrosis that differentiate different types of fibrotic lung disease and provides a standardized format for reporting results.
Relay Medical Corp. and Fio Corp., both of Toronto, reported the signing of distribution partners in the U.S. and France to market the Fionet Mobile COVID-19 testing and tracking platform, under a joint venture announced by the companies on Aug. 9, 2020. In France, Fionet will be distributed by Magentine Healthcare, of Saint-Clément-de-Rivière, France. Los Angeles-based Mylabbox will distribute the Fionet in the U.S.
Rhino Novi Inc., of Toronto, has entered a binding agreement to purchase Ontario-based Biolife Sciences Corp., a company focused on antibacterial products and noncontact temperature screening technology. The agreement calls for the issuance of 35,751,380 RNOV shares to Biolife’s current shareholders, the cancellation of 25 million shares held by current Rhino Novi shareholders, and transactional expenses for up to CA$50,000 (US$38,285), in exchange for 100% of the shares of Biolife, which will become a wholly owned subsidiary of Rhino Novi Inc. Rhino Novi has filed a corporate action with the Financial Industry Regulatory Authority to change its name to Biolife Sciences Corp.
Senseonics Holdings Inc., of Germantown, Md., said that three Medicare Administrative Contractors – Novitas Solutions Inc., First Coast Service Options Inc. and Wps Government Health Administrators – have issued positive local coverage determinations (LCDs) for the use of continuous glucose monitors, such as its Eversense CGM system. The LCDs are effective Oct. 19, 2020.
Salt Lake City-based Sg Blocks Inc. has entered the U.S. test lab market via a joint venture with Clarity Diagnostics LLC, of Boca Raton, Fla. Under the terms of the joint venture, Sg Blocks will have 51% ownership in the joint venture, Clarity Modular Lab Solutions (CMLS). CMLS’ first CLIA lab contract, Lab 1, will build a redundant main lab outside of Boca Raton.
Sonifi Health, of Sioux Falls, S.D., has joined the Siemens Connect Ecosystem, a network of experts in software development, IT, cybersecurity, remote and digital services and business intelligence.
Keystone Capital Partners, of New York, has provided foundational seed funding for Stella Diagnostics LLC, a New York-based molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. As part of the transaction, Daniel Wainstein, managing partner and chief operating officer of Keystone, will join Stella’s Board of directors.
Theator, of Tel Aviv-Yafo, Israel, has partnered with Tel Aviv Sourasky Medical Center to implement its AI-powered surgical intelligence platform in operating rooms at the hospital.